Overcoming neglect of kinetoplastid diseases

Science

Volumn 348, Issue 6238, 2015, Pages 974-976

  Bilbe, Graeme ^a  

^a Drugs for Neglected Diseases Initiative   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; BENZNIDAZOLE; EFLORNITHINE; FEXINIDAZOLE; MELARSOPROL; MILTEFOSINE; NIFURTIMOX; PAROMOMYCIN; POSACONAZOLE; RAVUCONAZOLE; ANTIPROTOZOAL AGENT;

DISEASE CONTROL; DRUG DEVELOPMENT; INFECTIOUS DISEASE; MORBIDITY; MORTALITY; PROTOZOAN; SCIENCE AND TECHNOLOGY; VACCINE; WORLD HEALTH ORGANIZATION;

AFRICAN TRYPANOSOMIASIS; ARTICLE; CHAGAS DISEASE; DISEASE ELIMINATION; HUMAN; KINETOPLASTIDA; LUMBAR PUNCTURE; NEGLECTED DISEASE; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PUBLIC HEALTH; SKIN DISEASE; TRYPANOSOMATID INFECTION; VISCERAL LEISHMANIASIS; ANIMAL; CHEMISTRY; DISEASE MODEL; DRUG DESIGN; DRUG EFFECTS; EUGLENOZOA INFECTIONS; LEISHMANIASIS; MOUSE; NEGLECTED DISEASES; TRANSMISSION; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS, AFRICAN;

KINETOPLASTIDA;

ANIMALS; ANTIPROTOZOAL AGENTS; CHAGAS DISEASE; DISEASE MODELS, ANIMAL; DRUG DESIGN; EUGLENOZOA INFECTIONS; HUMANS; KINETOPLASTIDA; LEISHMANIASIS; MICE; NEGLECTED DISEASES; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS, AFRICAN;

EID: 84930678674     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.aaa3683     Document Type: Article

References (11)

1. WHO/Department of control of neglected tropical diseases, Investing to overcome the global impact of neglected tropical diseases. Third WHO report on neglected tropical diseases (WHO, Geneva, Switzerland, 2015); see http://apps.who.int/iris/bitstream/10665/152781/1/9789241564861-eng.pdf.
2. B. Pedrique et al. Lancet Glob. Health 1, e371 (2013).
3. A. Arce et al., Euro Surveill. 18, 20546 (2013).
4. B. Monge-Maillo, F. F. Norman, I. Cruz, J. Alvar, R. López-Vélez, PLOS Negl. Trop. Dis. 8, e3021 (2014).
5. A. Hailu et al., PLOS Negl. Trop. Dis. 4, e709 (2010).
6. E. A. Khalil et al., PLOS Negl. Trop. Dis. 8, e2613 (2014).
7. M. D. Lewis et al., Cell. Microbiol. 16, 1285 (2014).
8. J. S. McCarthy et al., PLOS ONE 6, 6 (2011).
9. G. Eperon et al., Expert Rev. Anti Infect. Ther. 12, 1407 (2014).
10. I. Molina et al., N. Engl. J. Med. 370, 1899 (2014).
11. DNDi, Drug Trial for Leading Parasitic Killer of the Americas Shows Mixed Results But Provides New Evidence for Improved Therapy (DNDi, Geneva, Switzerland, 2013); see www.dndi.org/media-centre/press-releases/1700-e1224.html.